[CLSTR]
< Back to situations

[PERSON]

Thanos Dimopoulos

Featured in 12 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1158 sources · last updated

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema

[ACTIVE] [HEALTH] [US] [GR] [IT]

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ

[ACTIVE] [POLITICS] [GR]

Greek controversy over quantum medicine legitimacy

6 clusters · 64 sources · last updated

Latest: Greece Health Minister addresses bio-resonance equipment controversy

A public dispute has emerged in Greece regarding the legitimacy of ‘quantum medicine.’ The controversy began with a clash between Health Minister Adonis Georgiadis and Maria Karystianou, president of the ‘Elpida gia ti D

[QUIET] [HEALTH] [GR] [IT] [US]

Multiple myeloma treatment regulatory approvals

2 clusters · 16 sources · last updated

Latest: AIFA approves belantamab mafodotin for multiple myeloma in Italy

Regulatory authorities have granted approvals for new multiple myeloma treatments in the United States and Italy. In September 2026, the US Food and Drug Administration (FDA) issued accelerated approval for iberdomide.

[QUIET] [HEALTH] [US] [GR]

FDA approvals for ESR1-mutated breast cancer

2 clusters · 4 sources · last updated

Latest: FDA approvals advance treatment for ESR1-mutated breast cancer

The U.S. Food & Drug Administration has expanded treatment options for hormone receptor-positive/HER2-negative metastatic breast cancer by approving therapies targeting ESR1 mutations. In September 2026, the FDA granted

[QUIET] [HEALTH] [GR]

Research into cellular senescence and aging

2 clusters · 11 sources · last updated

Latest: Scientific research and practical strategies address cellular aging and senior well-being

Medical researchers are investigating cellular senescence as a primary therapeutic target for age-related diseases. Experts from the Alexandra Hospital and the National and Kapodistrian University of Athens have identifi

Also covered in